Literature DB >> 11732525

Production of human albumin solution: a continually developing colloid.

P Matejtschuk1, C H Dash, E W Gascoigne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11732525     DOI： 10.1093/bja/85.6.887

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  10 in total

1.  Moving albumin into the small volume resuscitation era.

Authors:  Fernando G Zampieri; Peter Buhl Hjortrup
Journal:  Intensive Care Med       Date:  2018-07-24       Impact factor: 17.440

2.  Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits.

Authors:  Junhyung Kim; Seongsung Kwak; Mi-Sun Park; Chang-Hoon Rhee; Gi-Hyeok Yang; Jangmi Lee; Woo-Chan Son; Won-Ho Kang
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

3.  Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome.

Authors:  Kazushi Tsuruga; Eishin Oki; Tomomi Yashiro; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2009-05-28       Impact factor: 3.714

4.  Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial.

Authors:  Samuel Akech; Samson Gwer; Richard Idro; Greg Fegan; Alice C Eziefula; Charles R J C Newton; Michael Levin; Kathryn Maitland
Journal:  PLoS Clin Trials       Date:  2006-09-15

Review 5.  Chemically Modified Biopolymers for the Formation of Biomedical Hydrogels.

Authors:  Victoria G Muir; Jason A Burdick
Journal:  Chem Rev       Date:  2020-12-23       Impact factor: 72.087

Review 6.  Albumin administration in the acutely ill: what is new and where next?

Authors:  Jean-Louis Vincent; James A Russell; Matthias Jacob; Greg Martin; Bertrand Guidet; Jan Wernerman; Ricard Ferrer; Ricard Ferrer Roca; Stuart A McCluskey; Luciano Gattinoni
Journal:  Crit Care       Date:  2014-07-16       Impact factor: 9.097

7.  Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations.

Authors:  Andrea Gilg; Mirja Harms; Lia-Raluca Olari; Ann-Kathrin Urbanowitz; Halvard Bonig; Jan Münch
Journal:  J Transl Med       Date:  2021-05-03       Impact factor: 8.440

Review 8.  Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy.

Authors:  Nicole Hryciw; Michael Joannidis; Swapnil Hiremath; Jeannie Callum; Edward G Clark
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-28       Impact factor: 8.237

9.  Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.

Authors:  Harald Olsen; Anders Andersen; Arve Nordbø; Ulf E Kongsgaard; Ole P Børmer
Journal:  BMC Clin Pharmacol       Date:  2004-03-29

Review 10.  Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality.

Authors:  Amit Patel; Michael A Laffan; Umeer Waheed; Stephen J Brett
Journal:  BMJ       Date:  2014-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.